Objective To compare clinical and laboratory data obtained from patients with primary
Antiphospholipid Syndrome (PAPS) with and without limb ischemia (LI). Methods A …

Background and Purpose—Because thromboembolic events are frequently observed in
primary antiphospholipid syndrome (PAPS), we assessed the risk factors for new thrombotic …

Aim: The study aims to evaluate the incidence of recurrent thromboses in patients with
primary antiphospholipid syndrome (PAPS) and its association with the presence of different …

Objectives The objective of this study was to investigate risk factors of microvascular
involvement and survival in Chinese patients with primary antiphospholipid syndrome …

Introduction Acute myocardial infarct/angina (AMI-A) is a possible complication in primary
antiphospholipid syndrome (pAPS) patients. This study compares data obtained from pAPS …

Antiprothrombin (aPT) antibodies may be detected by an enzyme-linked immunosorbent
assay (ELISA) using a purified antigen or a phosphatidylserine/prothrombin complex …

Introduction. Patients with antiphospholipid syndrome (APS) may have a large spectrum of
thrombotic clinical events (arterial or venous), but the factors that determine the occurrence …

Objective. To test the inflammation and immune activation hypothesis in primary thrombotic
APS (PAPS) and to identify clinical and laboratory factors related to inflammation and …

Objective To investigate if patients with Primary Antiphospholipid Syndrome (PAPS) with
venous and/or arterial thrombosis without traditional coronary artery disease (CAD) risk …

Objectives: To describe the characteristics of patients with antiphospholipid syndrome (APS)
in an Asian clinical practice setting. Methods: We conducted a single-center, retrospective …